Literature DB >> 2935120

Immobilization hypercalcemia following spinal cord injury.

F M Maynard.   

Abstract

Based on the author's experience with more than 20 cases of immobilization hypercalcemia following spinal cord injury, current concepts of this condition are presented. Symptoms may be mild or severe: laboratory findings are essential for differential diagnosis in older individuals, in whom preinjury Paget's disease and mild primary hyperparathyroidism must be ruled out. Most cases of immobilization hypercalcemia are seen in adolescent boys following recent spinal cord injury. Besides sex (male), risk factors include age (less than 21 years), complete neurologic injuries, high cervical levels of spinal cord injury, dehydration, and a prolonged period of immobilization. A preinjury history of large ingestion of milk and/or extreme exposure to sunshine may also be contributory factors. Therapy includes vigorous hydration, saline infusions and diuretics, calcitonin, and steroids. The clinical course, without treatment, may be prolonged to 14 months, but the condition is always self-limiting.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2935120

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  16 in total

1.  Effect of a convenient single 90-mg pamidronate dose on biochemical markers of bone metabolism in patients with acute spinal cord injury.

Authors:  Jeffrey I Mechanick; Kan Liu; David M Nierman; Adam Stein
Journal:  J Spinal Cord Med       Date:  2006       Impact factor: 1.985

Review 2.  Bone loss and muscle atrophy in spinal cord injury: epidemiology, fracture prediction, and rehabilitation strategies.

Authors:  Lora Giangregorio; Neil McCartney
Journal:  J Spinal Cord Med       Date:  2006       Impact factor: 1.985

3.  Immobilization hypercalcaemia responding to intravenous pamidronate sodium therapy.

Authors:  H D McIntyre; D P Cameron; S M Urquhart; W E Davies
Journal:  Postgrad Med J       Date:  1989-04       Impact factor: 2.401

4.  Immobilization induced hypercalcemia.

Authors:  Edgar Alonso Cano-Torres; Arnulfo González-Cantú; Gabriela Hinojosa-Garza; Fernando Castilleja-Leal
Journal:  Clin Cases Miner Bone Metab       Date:  2016-05-11

Review 5.  Osteoporosis after spinal cord injury.

Authors:  Sheng-Dan Jiang; Li-Yang Dai; Lei-Sheng Jiang
Journal:  Osteoporos Int       Date:  2005-10-11       Impact factor: 4.507

Review 6.  Vitamin D and spinal cord injury: should we care?

Authors:  J Lamarche; G Mailhot
Journal:  Spinal Cord       Date:  2016-09-20       Impact factor: 2.772

7.  Effects of spinal cord injury on osteoblastogenesis, osteoclastogenesis and gene expression profiling in osteoblasts in young rats.

Authors:  S-D Jiang; L-S Jiang; L-Y Dai
Journal:  Osteoporos Int       Date:  2006-10-12       Impact factor: 4.507

8.  Immobilisation-induced hypercalcemia following spinal cord injury affecting the kidney function in two young native Greenlanders.

Authors:  Michael V Linstow; Fin Biering-Sørensen
Journal:  Spinal Cord Ser Cases       Date:  2017-04-13

9.  Aminohydroxypropylidene bisphosphonate (AHPrBP) treatment of severe immobilization hypercalcaemia in a young patient.

Authors:  N Varache; M Audran; P Clochon; A Lortholary; G Bouachour; P Alquier; M F Basle
Journal:  Clin Rheumatol       Date:  1991-09       Impact factor: 2.980

10.  Five-year longitudinal bone evaluations in individuals with chronic complete spinal cord injury.

Authors:  Douglas E Garland; Rodney H Adkins; Charles A Stewart
Journal:  J Spinal Cord Med       Date:  2008       Impact factor: 1.985

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.